DTL
TERN

Dynamic Technology Lab’s Terns Pharmaceuticals TERN Stock Holding History

Dynamic Technology Lab’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-66,576
Closed -$500K – 1084
2025
Q3 		$500K Buy
66,576
+46,831
+237% +$299K 0.08% 423
2025
Q2 		$74K Buy
19,745
+1,167
+6% +$3.65K 0.01% 859
2025
Q1 		$51K Buy
+18,578
New +$75.9K 0.01% 930
2024
Q2 		– Sell
-21,206
Closed -$139K – 1384
2024
Q1 		$139K Buy
21,206
+4,884
+30% +$31.9K 0.01% 950
2023
Q4 		$106K Buy
+16,322
New +$86.3K 0.01% 939
2023
Q3 		– Sell
-12,101
Closed -$106K – 1321
2023
Q2 		$106K Buy
+12,101
New +$141K 0.01% 898
2023
Q1 		– Sell
-15,709
Closed -$160K – 1502
2022
Q4 		$160K Buy
+15,709
New +$105K 0.02% 941

Other funds holding TERN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CLGM
Capitolis Liquid Global Markets New York $15.7B AUM 30.78% 1-Year Est. Return

Dynamic Technology Lab's TERN Position: Q4 2025 in Review

Dynamic Technology Lab sold out of Terns Pharmaceuticals (TERN) in Q4 2025, closing a stake of 66,576 shares — an estimated $500K sold.

Dynamic Technology Lab first reported a position in TERN in Q4 2022 and held it in 7 quarters. The position peaked at $500K in Q3 2025. 248 funds tracked by Wall St. Rank hold TERN as of Q4 2025.

  • Dynamic Technology Lab reported no remaining Terns Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Dynamic Technology Lab sold 66,576 Terns Pharmaceuticals shares in Q4 2025, an estimated $500K.
  • Dynamic Technology Lab first reported a position in Terns Pharmaceuticals in Q4 2022 and held it in 7 quarters.
  • Dynamic Technology Lab's Terns Pharmaceuticals position peaked at $500K in Q3 2025.
  • 248 funds tracked by Wall St. Rank held Terns Pharmaceuticals as of Q4 2025.

Based on Dynamic Technology Lab's 13F filing for Q4 2025, filed 13 Feb 2026.